Prospective randomised study of doxorubicin [DC Bead] in the treatment of hepatocellular carcinoma by drug-eluting bead embolisation (PRECISION V).
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2010
At a glance
- Drugs Doxorubicin (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms PRECISION V
- Sponsors Biocompatibles International
- 31 Aug 2018 Biomarkers information updated
- 14 Jun 2010 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Tolerability results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History